Breakthrough order for RayStation® in Asia

RaySearch Laboratories AB has received an order for its RayStation® treatment
planning system from Samsung Medical Center in Seoul, South Korea.
Samsung Medical Center (SMC) was founded in 1994 and is a teaching hospital
affiliated with Sungkyunkwan University's school of medicine. SMC has a large
cancer center that treated more than 3,600 patients with radiation therapy in
2010. The center offers a wide range of advanced treatment options within
radiation therapy and is also currently building a new facility for proton
therapy. Proton therapy is the most sophisticated form of radiation therapy and
offers even better precision than conventional radiation therapy with photons.
It requires very advanced specialized equipment so it is only carried out in a
small number of centers globally. The new proton center will be equipped with an
accelerator from Sumitomo Heavy Industries and is scheduled to be operational in
2014. SMC has now ordered RaySearch’s RayStation® treatment planning system for
planning of all proton treatments at SMC. The system will incorporate all the
latest advanced tools and algorithms for optimization and dose computation to
take full advantage of the potential that proton therapy offers.

“This is the
first RayStation® order in Asia and therefore a very important milestone for
RaySearch. Asia is the largest growth market in our field as the use of
radiation therapy is growing much faster there than in other regions. Samsung
Medical Center is a state-of-the-art cancer center and we are delighted that
they have selected us to provide a comprehensive solution for proton treatment
planning. Proton therapy is an exciting and rapidly evolving field of radiation
therapy and I believe that the new order strengthens our position in this
segment significantly”, says Johan Löf, CEO of RaySearch.

About
RayStation®
RayStation® integrates all RaySearch’s advanced treatment planning
solutions into a flexible treatment planning system. It combines unique features
such as multi-criteria optimization tools with full support for 4D adaptive
radiation therapy. It also includes functionality such as RaySearch’s market
-leading algorithms for IMRT and VMAT optimization and highly accurate dose
engines for both photon and proton therapy. The system is built on the latest
software architecture and has a graphical user interface offering state-of-the
-art usability.

About RaySearch
RaySearch Laboratories is a medical
technology company that develops advanced software solutions for improved
radiation therapy of cancer. RaySearch’s products are mainly sold through
license agreements with leading partners such as Philips, Nucletron, IBA
Dosimetry, Varian, Accuray and Siemens. To date, 15 products have been launched
through partners and RaySearch’s software is used at some 1,800 clinics in more
than 30 countries. In addition, RaySearch offers the proprietary treatment
planning system RayStation® directly to clinics. RaySearch was founded in 2000
as a spin-off from Karolinska Institutet in Stockholm and the company is listed
in the Small Cap segment on NASDAQ OMX Stockholm.

For more information about
RaySearch, visit www.raysearchlabs.com

 

For further information, please
contact:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone:
+46 (0)8-545 061 30
johan.lof@raysearchlabs.com